Role for cyclin-dependent kinase 2 in mitosis exit

被引:36
|
作者
D'Angiolella, V
Costanzo, V
Gottesman, ME
Avvedimento, EV
Gautier, J
Grieco, D
机构
[1] Univ Catanzaro, Sch Med, Dipartimento Med Sperimentale G Salvatore, Catanzaro, Italy
[2] Univ Naples Federico II, Sch Med, Dipartimento Biol & Patol Mol & Cellulare L Calif, I-80131 Naples, Italy
[3] Columbia Univ, Inst Canc Res, New York, NY 10032 USA
[4] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA
[5] Columbia Univ, Dept Dermatol, New York, NY 10032 USA
关键词
D O I
10.1016/S0960-9822(01)00352-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitosis requires cyclin-dependent kinase (cdk) 1-cyclin B activity [1]. Exit from mitosis depends on the inactivation of the complex by the degradation of cyclin B [2]. Cdk2 is also active during mitosis [3, 4]. In Xenopus egg extracts, cdk2 is primarily in complex with cyclin E, which is stable [5]. At the end of mitosis, downregulation of cdk2-cyclin E activity is accompanied by inhibitory phosphorylation of cdk2 [6]. Here, we show that cdk2-cyclin E activity maintains cdk1-cyclin B during mitosis. At mitosis exit, cdk2 is inactivated prior to cdk1. The loss of cdk2 activity follows and depends upon an increase in protein kinase A (PKA) activity. Prematurely inactivating cdk2 advances the time of cyclin B degradation and cdk1 inactivation. Blocking PKA, instead, stabilizes cdk2 activity and inhibits cyclin B degradation and cdk1 inactivation. The stabilization of cdk1-cyclin B is also induced by a mutant cdk2-cyclin E complex that is resistant to inhibitory phosphorylation. P21-Cip1, which inhibits both wild-type and mutant cdk2-cyclin E, reverses mitotic arrest under either condition. Our findings indicate that the proteolysis-independent downregulation of cdk2 activity at the end of mitosis depends on PKA and is required to activate the proteolysis cascade that leads to mitosis exit.
引用
收藏
页码:1221 / 1226
页数:6
相关论文
共 50 条
  • [1] Inhibitory Phosphorylation of Cyclin-Dependent Kinase 1 as a Compensatory Mechanism for Mitosis Exit
    Chow, Jeremy P. H.
    Poon, Randy Y. C.
    Ma, Hoi Tang
    MOLECULAR AND CELLULAR BIOLOGY, 2011, 31 (07) : 1478 - 1491
  • [2] Mutual regulation of cyclin-dependent kinase and the mitotic exit network
    Koenig, Cornelia
    Maekawa, Hiromi
    Schiebel, Elmar
    JOURNAL OF CELL BIOLOGY, 2010, 188 (03): : 351 - 368
  • [3] Role of cyclin-dependent kinase inhibitors in the timely exit of cell cycle by osteoclast precursors
    Sankar, U
    Ostrowski, MC
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 137A - 137A
  • [4] Knockdown of cyclin-dependent kinase inhibitors by RNAi induces cardiomyocyte mitosis
    Di Stefano, Valeria
    Crescenzi, Marco
    Capogrossi, Maurizio C.
    Martelli, Fabio
    CIRCULATION RESEARCH, 2007, 101 (05) : E73 - E73
  • [5] Regulation of AMP-Activated Protein Kinase by Cyclin-Dependent Kinase 1 in Mitosis
    Stauffer, Seth D.
    Chen, Xingcheng
    Chen, Yuanhong
    Dong, Jixin
    FASEB JOURNAL, 2016, 30
  • [6] The cyclin-dependent kinase inhibitor Roughex is involved in mitotic exit in Drosophila
    Foley, E
    Sprenger, F
    CURRENT BIOLOGY, 2001, 11 (03) : 151 - 160
  • [7] Cyclins, cyclin-dependent kinases, cyclin-dependent kinase inhibitors and their role in head and neck cancer
    Jeannon, JP
    Wilson, JA
    CLINICAL OTOLARYNGOLOGY, 1998, 23 (05): : 420 - 424
  • [8] The role of cyclin-dependent kinase 5 in neuropathic pain
    Gomez, Kimberly
    Vallecillo, Tissiana G. M.
    Moutal, Aubin
    Perez-Miller, Samantha
    Delgado-Lezama, Rodolfo
    Felix, Ricardo
    Khanna, Rajesh
    PAIN, 2020, 161 (12) : 2674 - 2689
  • [9] Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
    Giannone, Gaia
    Tuninetti, Valentina
    Ghisoni, Eleonora
    Genta, Sofia
    Scotto, Giulia
    Mittica, Gloria
    Valabrega, Giorgio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (09)
  • [10] ROLE OF THE CYCLIN-DEPENDENT KINASE INHIBITORS IN THE DEVELOPMENT OF CANCER
    HIRAMA, T
    KOEFFLER, HP
    BLOOD, 1995, 86 (03) : 841 - 854